GlassScriptPhysician profile
Timothy H Ward
NPI 1528022050
$4,376.91
in general payments reported to CMS, 2019-2025
23 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $1,250 · 2021: $656 · 2022: $787 · 2023: $551 · 2024: $409 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,518.62 | 2019-2024 | Proclaim, Eterna |
| Nevro Corp. | $817.72 | 2019-2024 | Senza |
| Collegium Pharmaceutical, INC. | $784.74 | 2019-2025 | Belbuca, Xtampza |
| Pfizer INC. | $169.03 | 2019-2020 | |
| Pacira Therapeutics, INC. | $150.47 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $146.64 | 2022-2024 | Ztlido |
| Takeda Pharmaceuticals U.S.A., INC. | $131.17 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $107.28 | 2019-2021 | |
| Boston Scientific Corporation | $95.12 | 2020-2021 | |
| Globus Medical, INC. | $79.17 | 2025 | Senza |
| Almatica Pharma LLC | $67.01 | 2022-2023 | Gralise |
| Medtronic, INC. | $60.14 | 2022-2023 | Intellis Adaptivestim |
| Lilly USA, LLC | $33.23 | 2022 | |
| Redhill Biopharma INC. | $29.94 | 2020 | |
| Medtronic USA, INC. | $29.13 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $26.32 | 2022 | |
| Bioventus LLC | $23.90 | 2022 | |
| Depuy Synthes Sales INC. | $23.07 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.77 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.27 | 2023 | Zilretta |
| Shionogi INC | $16.87 | 2019 | |
| Stryker Corporation | $14.97 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.